Cambridge Orthopaedic Labs: Shareholder Update Q1, 2022

The last six months have been full of many significant moves ahead for the COL team. The first quarter culminated with the American Academy of Orthopaedic Surgeons (AAOS) meeting in Chicago that was attended by Dr. Bajwa and me and 20,000 orthopaedic professionals. At the meeting we began the process of introduction of PolyArmour (PA) to both the physician and orthopaedic corporate audiences in advance of our upcoming FDA clearance.

Shareholder Update